Search

everythinglearnresearchcommunity

for

Search:↓

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Topical ruxolitinib quickly improves non-segmental vitiligo.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Belimumab may cause hair loss in lupus patients.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Rheumatology clinics should always provide preconception counseling for women on DMARDs.

RUM-loaded SLN shows promise for treating acne and hair loss topically.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Dupilumab improves skin microbiome balance in atopic dermatitis patients.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Dupilumab may help treat alopecia areata without needing high IgE levels.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

Isotretinoin treatment increases p53 levels in the skin, which may explain its effectiveness against acne.

Isotretinoin treatment increases p53 levels in the skin, which may explain its effectiveness against acne.

JAK inhibitors may help improve symptoms in adults with APECED.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Sulfasalazine can cause severe allergic reactions leading to long-term autoimmune issues like hair loss and skin discoloration.

Abatacept may help some people with alopecia areata regrow hair.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.